TSP Capital Management Group »

Celldex Therapeutics shares owned by TSP Capital Management Group

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by TSP Capital Management Group from 13F filings

Historical chart of TSP Capital Management Group investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by TSP Capital Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by TSP Capital Management Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 252k 39.66
2023-09-30 $6.9M 252k 27.52
2023-06-30 $8.5M 252k 33.93
2023-03-31 $9.1M 252k 35.98
2022-12-31 $12M 270k 44.57
2022-09-30 $7.5M 267k 28.11
2022-06-30 $7.2M 267k 26.96
2022-03-31 $9.2M 269k 34.06
2021-12-31 $9.8M 254k 38.64
2021-09-30 $15M 271k 53.99
2021-06-30 $11M 340k 33.44
2021-03-31 $7.4M 359k 20.60
2020-12-31 $7.1M 403k 17.52
2020-09-30 $6.6M 442k 14.83
2020-06-30 $4.8M 368k 13.00
2020-03-31 $681k 410k 1.66
2019-12-31 $796k 357k 2.23
2019-09-30 $350k 164k 2.13
2019-06-30 $416k 155k 2.68
2019-03-31 $770k 156k 4.92